You have 0 free articles left this month.
Big Law

Ginkgo Bioworks, Microba Life Sciences enter development agreement

NYSE-listed Ginkgo Bioworks (NYSE: DNA) has entered into a technical development agreement with ASX-listed Microba Life Sciences (ASX: MAP).

April 29, 2022 • By Jerome Doraisamy
Share this article on:
Facebook X LinkedIn
MinterEllison
expand image

Firm: MinterEllison (Ginkgo Bioworks)

This content is available exclusively to Lawyers Weekly premium members.
Deal: The development agreement will facilitate Ginkgo and Microba’s collaboration on projects that develop live biotherapeutics for lupus, psoriatic arthritis and other autoimmune liver diseases – “all with the goal of improving treatment”, Minter said in a statement.

 
 

Area: Capital markets

Value: N/A

Key players: The Minter team was led by partner James Hutton, who was supported by corporate specialist Esmond Prowse and a cross-disciplinary MinterEllison team comprising specialists in intellectual property, tax, foreign investment, trade and transaction solutions.

Deal significance: Mr Hutton said: “We’re delighted to support Ginkgo in this transaction to help them work towards their collaboration and great health outcomes for the community.

“The pandemic has continued to put a spotlight on the importance of life sciences and biotech for the wellbeing of the global community. Global partnerships like Ginkgo and Microba’s are a great example of how organisations are harnessing this to rapidly develop and improve diagnostics and treatment options.

Discover logo VIEW ALL

“This also continues a theme of the growing importance of utilising computer power in life science platform technologies.”

Want to see more stories from trusted news sources?
Make Lawyers Weekly a preferred news source on Google.
Click here to add Lawyers Weekly as a preferred news source.

Jerome Doraisamy

Jerome Doraisamy

Author

Jerome Doraisamy is the managing editor of professional services (including Lawyers Weekly, HR Leader, Accountants Daily, and Accounting Times). He is also the author of The Wellness Doctrines book series, an admitted solicitor in New South Wales, and a board director of the Minds Count Foundation.

You can email Jerome at: This email address is being protected from spambots. You need JavaScript enabled to view it. 

Know More
Tags